Drug Shortage Report for TWINRIX
Report ID | 16553 |
Drug Identification Number | 02230578 |
Brand name | TWINRIX |
Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 720UNIT 20MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-07-18 |
Estimated end date | 2017-12-07 |
Actual end date | 2017-12-04 |
Shortage status | Resolved |
Updated date | 2017-12-06 |
Company comments | Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.